论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
司库奇尤单抗治疗系统性红斑狼疮合并银屑病一例报告并文献复习
Authors Dai B, Bai Y, Yu H, Huang Q, Wang L
Received 19 September 2023
Accepted for publication 7 December 2023
Published 15 December 2023 Volume 2023:16 Pages 3589—3594
DOI https://doi.org/10.2147/CCID.S440977
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Rungsima Wanitphakdeedecha
Abstract: Although psoriasis and systemic lupus erythematosus are both immune abnormalities, there are few reports on Ps combined with SLE in China and abroad. We present a case of a 23-year-old female with a 10-year history of psoriasis, who had a relapse with significant joint symptoms and a PASI score of 35.6, along with several positive antibodies, including antinuclear antibodies, elevated CRP and ESR, and was diagnosed with psoriasis and SLE. She has been treated with secukinumab 300 mg subcutaneously, improving her condition. She is currently being followed up. The PubMed, SCOPUS, and ISI Web of Science databases were thoroughly searched for English studies reporting psoriasis with systemic lupus erythematosus and treated using biologics. Three case reports/series were included after the screening. Our case report provides a reference for clinicians using secukinumab to treat psoriasis combined with SLE. However, further research is needed to determine whether it can be widely used or if there are common signaling pathways that can be interfered with the pathogenesis of the diseases.
Keywords: psoriasis, systemic lupus erythematosus, secukinumab